Levofloxacin Susceptibility Testing for Helicobacter pylori in China: Comparison of E-Test and Disk Diffusion Method

Helicobacter

Volumn 16, Issue 2, 2011, Pages 119-123

  Yu, Chaohui ^a   Li, Lan ^a   Chen, Wenguo ^a   Jiao, Yangwen ^a   Yang, Ningmin ^b   Yang, En ^b   Zhang, Jianzhong ^c   Chen, Lihua ^a   Li, Youming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Hangzhou Zhiyuan Institute of Medical Diagnostics   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Disk diffusion; E test; Helicobacter pylori; Levofloxacin

Indexed keywords

LEVOFLOXACIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHINESE; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MALE; MICROBIAL SENSITIVITY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STOMACH BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OFLOXACIN;

HELICOBACTER PYLORI;

EID: 79952714642     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00820.x     Document Type: Article

References (26)

1. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis 2008;40:619-26.
2. Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol 2010;5:639-48.
3. Zullo A, Perna F, Hassan C, Ricci C, Saracino I, Morini S, Vaira D Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007;25:1429-34.
4. Di Mario F, Cavallaro LG, Scarpignato C. 'Rescue' therapies for the management of Helicobacter pylori infection. Dig Dis 2006;24:113-30.
5. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
6. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374-84.
7. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
8. Mishra KK, Srivastava S, Garg A, Ayyagari A. Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods. Curr Microbiol 2006;53:329-34.
9. Lang L, García F. Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica. Int J Antimicrob Agents 2004;24:572-7.
10. Chang WL, Sheu BS, Cheng HC, Yang YJ, Yang HB, Wu JJ. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. J Gastroenterol Hepatol 2009;24:1230-5.
11. Hung IF, Chan P, Leung S, et al. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Helicobacter 2009;14:505-11.
12. Diaz Reganon J, Alarcon T, Domingo D, Lopez-Brea M. Susceptibility of 36 Helicobacter pylori clinical isolates to four-first-line antibiotics and virulence factors. Rev Esp Quimioter 2006;19:34-8.
13. Cibrelus LA, Perez de Ayala A, Alarcon T, Martínez MJ, López-Brea M. In vitro efficiency of ciprofloxacin and rifampicin as potential second-line treatment in Spanish Helicobacter pylori clinical isolates (Abstract). Helicobacter 2006;11:402.
14. Lee CC, Lee VW, Chan FK, Ling TK. Levofloxacin-resistant Helicobacter pylori in Hong Kong. Chemotherapy 2008;54:50-3.
15. Miyachi H, Miki I, Aoyama N, et al. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter 2006;11:243-9.
16. Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 2007;29:389-96.
17. Bogaerts P, Berhin C, Nizet H, Glupczynski Y. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter 2006;11:441-5.
18. Bina JE, Alm RA, Uria-Nickelsen M, Thomas SR, Trust TJ, Hancock RE. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother 2000;44:248-54.
19. Perna F, Gatta L, Figura N, Ricci C, Tampieri A, Holton J, Miglioli M, Vaira D. Susceptibility of Helicobacter pylori to metronidazole. Am J Gastroenterol 2003;98:2157-61.
20. Best LM, Haldane DJ, Keelan M, et al. Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob Agents Chemother 2003;47:3138-44.
21. Glupczynski Y, Broutet N, Cantagrel A, Andersen LP, Alarcon T, López-Brea M, Mègraud F. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2002;21:549-52.
22. Grignon B, Tankovic J, Mégraud F, Glupozynski Y, Husson MO, Conroy MC, Emond JP, Loulergue J, Raymond J, Fauchère JL. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist 2002;8:61-6.
23. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997;35:1842-6.
24. Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother 2007;13:291-5.
25. Boyanova L, Stancheva I, Spassova Z, Katzarov N, Mitov I, Koumanova R. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. J Med Microbiol 2000;49:415-8.
26. Kulsuntiwong P, Chomvarin C, Chaicumpar K, Namwat W, Kaewkes W, Mairiang P, Sangchan A. Antimicrobial susceptibility of Helicobacter pylori isolated from gastric biopsies in dyspeptic patients. Southeast Asian J Trop Med Public Health 2008;39:1102-9.